Patient With Stage IV NSCLC and CNS Metastasis With EGFR Exon 18-25 Kinase Domain Duplication With Response to Osimertinib as a First-Line Therapy. (2021) - Taek Kim, Jong; Zhang, Wenjuan; Lopategui, Jean; Vail, Eric; Balmanoukian, Ani